Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIQ-AI Regulatory News (IQAI)

  • There is currently no data for IQAI

Proposed disposals

30 Mar 2012 07:00

RNS Number : 4328A
Flying Brands Limited
30 March 2012
 

30 March 2012

Flying Brands Limited (the "Company" or the "Group")

Proposed sale of the Garden Bird Supplies, Garden Centre Online and Listen2 businesses

The Board is pleased to announce that terms have been agreed, subject to shareholder approval, to dispose of (first) the Garden Bird Supplies ("GBS"), Garden Centre Online ("GCO") and Listen2 businesses to The Garden and Home Trading Company Limited (a subsidiary of MBL Group PLC) for a gross consideration of £0.72 million, and (second) certain intellectual property of GCO to Williams Commerce Limited for a gross consideration of £0.08m (together the "Disposals"). The consideration will be satisfied in cash on completion of each Disposal.

GBS is an online, catalogue and telephone-based retail business selling bird and other animal foods, wildlife products and gifts. GCO is an online and telephone-based retail business for garden equipment. Listen2 is a catalogue and telephone-based retail business involving the sale of music, DVDs and audio books.

For the year ending 31 December 2010, GBS, GCO and Listen2 generated combined revenue of approximately £6 million and an operating profit of £0.6 million. For the six months ending 1 July 2011, the businesses generated combined revenue of approximately £3.1 million and a small operating loss. The net book value of the assets subject of the Disposal was £4.9 million at 1 July 2011.

Following the sale of the properties at Retreat Farm and Meadow Springs in December 2011, and the proposed sale of the Gifts Division, the Disposals are a continuation of the Board's strategy to enhance shareholder value. The Disposals will result in the Group's exit from the wild bird food industry previously served by GBS, will remove the online outlet, GCO, from the garden division's web-based retail operations and will result in the Group's full exit from the entertainment retail market previously served by Listen2. If the Disposals and the sale of the Gifts Division (as announced on 21 February 2012) complete, the remaining businesses and associated assets of the Company will comprise the Gardening Direct business, the Retreat Farm growing and live despatch businesses and the Retreat Farm freehold property itself.

The Disposals are a Class 1 transaction and are therefore subject to shareholder approval under the Listing Rules. A circular containing details of the Disposals, together with the disposal of the Gifts Division, and a notice of extraordinary general meeting will be sent to shareholders in due course.

  

For further information, please contact:

Flying Brands Limited 01245 228 300Stephen Cook, Chief ExecutiveStuart Dootson, Finance Director

Smithfield Consultants 020 7360 4900John Kiely

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
DISZBLBXLXFBBBF
Date   Source Headline
27th May 20257:00 amRNSChange of Name
22nd May 20252:23 pmRNSResult of AGM
2nd May 20257:29 amRNSApplication: FDA Breakthrough Therapy Designation
29th Apr 202510:49 amRNSNotice of AGM
25th Apr 20251:46 pmRNSPublication of Annual Report
11th Apr 20253:32 pmRNSPromising Preliminary Results of Phase 1 Study
18th Mar 202510:38 amRNSPlacing to raise £250,000
3rd Feb 20257:00 amRNSIB Expands Distribution with Blackford
22nd Jan 20257:00 amRNSOperations Update
10th Jan 20257:49 amRNSIB and Prism Secure First Installation
20th Nov 20247:00 amRNSImaging Biometrics Expands Distribution
19th Nov 202411:27 amRNSBoard Changes
5th Nov 20247:00 amRNSNew Patent Application and Trading Update
15th Oct 202410:28 amRNSHolding(s) in Company
14th Oct 202412:08 pmRNSHolding(s) in Company
14th Oct 202412:05 pmRNSPDMR dealing and TR1 announcement
11th Oct 202410:42 amRNSAcquisition of Interest by Braveheart
25th Jun 20249:59 amRNSIB Opens Expanded Access Program
14th Jun 20248:38 amRNSClinical Trial Updates
29th May 20243:08 pmRNSResult of AGM
23rd May 20247:00 amRNSMajor East Coast Health System Chooses IB Nimble
20th May 20247:10 amRNSSecond FDA Rare Pediatric Disease Designation
17th May 20247:00 amRNSIB Software Enhances Clinical Decision-Making
10th May 20248:15 amRNSRare Pediatric Disease Designation Granted to GaM
2nd May 202412:47 pmRNSIB Announces Expanded Access Program for GaM
29th Apr 20243:26 pmRNSPublication of Annual Report
5th Mar 20247:00 amRNSGrant of Options
1st Mar 20248:22 amRNSHolding(s) in Company
1st Mar 20248:20 amRNSHolding(s) in Company
26th Feb 20247:00 amRNSResult of Broker Option and Total Voting Rights
22nd Feb 20247:00 amRNSPlacing and Broker Option
9th Feb 202412:49 pmRNSFDA Application Update
2nd Feb 20248:39 amRNSIB awarded a $100,000 grant
22nd Jan 202410:05 amRNSHolding(s) in Company
15th Jan 20247:01 amRNSDirector Dealings and Conversion of CLNs
15th Jan 20247:00 amRNSHolding(s) in Company
10th Jan 20247:00 amRNSIB Launching an Expanded Access Program for GaM
19th Dec 20232:29 pmRNSImaging Biometrics granted FDA “Fast-Track”
5th Dec 202310:58 amRNSIQ-AI Announces Positive Interim Phase 1 Results
20th Nov 20231:42 pmRNSHolding(s) in Company
9th Nov 202311:38 amRNSDirector Dealing and Conversion of CLNs
8th Nov 202310:59 amRNSApplication for Pediatric Rare Disease Designation
6th Nov 20231:02 pmRNSHolding(s) in Company
18th Oct 20232:29 pmRNSUpdate Regarding Imaging Biometrics LLC
13th Oct 20238:55 amRNSIB Letter to Shareholders
9th Oct 20237:00 amRNSOrphan Drug Status to GaM and Total Voting Rights
3rd Oct 202311:30 amRNSHolding(s) in Company
19th Sep 20232:32 pmRNSIQ-AI shares cease trading on the OTCQB
8th Sep 20237:00 amRNSReduced Gadolinium Approach Validated'
18th Aug 202312:06 pmRNSUpdate on Collaboration Agreement with Mayo Clinic

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.